211 related articles for article (PubMed ID: 31972611)
1. Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis.
Kempinska-Podhorodecka A; Blatkiewicz M; Wunsch E; Krupa L; Gutkowski K; Milkiewicz P; Milkiewicz M
Clin Transl Gastroenterol; 2020 Jan; 11(1):e00112. PubMed ID: 31972611
[TBL] [Abstract][Full Text] [Related]
2. Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis.
Kempinska-Podhorodecka A; Adamowicz M; Ostrycharz E; Chmielarz M; Wójcicki M; Milkiewicz P; Milkiewicz M
Sci Rep; 2021 May; 11(1):10134. PubMed ID: 33980925
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Mismatch Repair and the SOCS1/p53 Axis by microRNA-155 in the Colon of Patients with Primary Sclerosing Cholangitis.
Adamowicz M; Stukan I; Milkiewicz P; Bialek A; Milkiewicz M; Kempinska-Podhorodecka A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563301
[TBL] [Abstract][Full Text] [Related]
4. The Role of hsa-miR-125b-5p Interaction with S1P/Ceramide Axis in the Potential Development of Inflammation-Associated Colon Cancer in Primary Sclerosing Cholangitis.
Abramczyk J; Milkiewicz M; Hula B; Milkiewicz P; Kempinska-Podhorodecka A
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298127
[TBL] [Abstract][Full Text] [Related]
5. Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.
Torres J; Bao X; Iuga AC; Chen A; Harpaz N; Ullman T; Cohen BL; Pineton de Chambrun G; Asciutti S; Odin JA; Sachar DB; Gaskins HR; Setchell K; Colombel JF; Itzkowitz SH
Inflamm Bowel Dis; 2013 Feb; 19(2):275-82. PubMed ID: 23348121
[TBL] [Abstract][Full Text] [Related]
6. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Eaton JE; Silveira MG; Pardi DS; Sinakos E; Kowdley KV; Luketic VA; Harrison ME; McCashland T; Befeler AS; Harnois D; Jorgensen R; Petz J; Lindor KD
Am J Gastroenterol; 2011 Sep; 106(9):1638-45. PubMed ID: 21556038
[TBL] [Abstract][Full Text] [Related]
7. Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis.
Wohl P; Hucl T; Drastich P; Kamenar D; Spicak J; Honsova E; Sticova E; Lodererova A; Matous J; Hill M; Wohl P; Kucera M
World J Gastroenterol; 2013; 19(14):2234-41. PubMed ID: 23599650
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid in patients with ulcerative colitis and primary sclerosing cholangitis for prevention of colon cancer: a meta-analysis.
Ashraf I; Choudhary A; Arif M; Matteson ML; Hammad HT; Puli SR; Bechtold ML
Indian J Gastroenterol; 2012 Apr; 31(2):69-74. PubMed ID: 22528343
[TBL] [Abstract][Full Text] [Related]
9. High Serum sCD40 and a Distinct Colonic T Cell Profile in Ulcerative Colitis Associated With Primary Sclerosing Cholangitis.
Lampinen M; Vessby J; Fredricsson A; Wanders A; Rorsman F; Carlson M
J Crohns Colitis; 2019 Mar; 13(3):341-350. PubMed ID: 30383225
[TBL] [Abstract][Full Text] [Related]
10. Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Frequently Have Subclinical Inflammation in the Proximal Colon.
Krugliak Cleveland N; Rubin DT; Hart J; Weber CR; Meckel K; Tran AL; Aelvoet AS; Pan I; Gonsalves A; Gaetano JN; Williams KM; Wroblewski K; Jabri B; Pekow J
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):68-74. PubMed ID: 28756053
[TBL] [Abstract][Full Text] [Related]
11. Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.
Vessby J; Lampinen M; Åberg M; Rorsman F; Siegbahn A; Wanders A; Carlson M
Ups J Med Sci; 2019 Nov; 124(4):238-245. PubMed ID: 31774347
[No Abstract] [Full Text] [Related]
12. Duration and severity of primary sclerosing cholangitis is not associated with risk of neoplastic changes in the colon in patients with ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Lewis B; Lashner BA; Remzi FH; Shen B; Kiran RP
Gastrointest Endosc; 2012 May; 75(5):1045-1054.e1. PubMed ID: 22405258
[TBL] [Abstract][Full Text] [Related]
13. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
[TBL] [Abstract][Full Text] [Related]
14. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Brentnall TA; Haggitt RC; Rabinovitch PS; Kimmey MB; Bronner MP; Levine DS; Kowdley KV; Stevens AC; Crispin DA; Emond M; Rubin CE
Gastroenterology; 1996 Feb; 110(2):331-8. PubMed ID: 8566577
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-346 mediates tumor necrosis factor α-induced downregulation of gut epithelial vitamin D receptor in inflammatory bowel diseases.
Chen Y; Du J; Zhang Z; Liu T; Shi Y; Ge X; Li YC
Inflamm Bowel Dis; 2014 Nov; 20(11):1910-8. PubMed ID: 25192497
[TBL] [Abstract][Full Text] [Related]
16. Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.
Broomé U; Löfberg R; Veress B; Eriksson LS
Hepatology; 1995 Nov; 22(5):1404-8. PubMed ID: 7590655
[TBL] [Abstract][Full Text] [Related]
17. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience.
Wang MH; Mousa OY; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Cushing KC; Monroe K; Nix BD; Newberry RD; Faubion WA
Inflamm Bowel Dis; 2020 Apr; 26(5):774-779. PubMed ID: 31626701
[TBL] [Abstract][Full Text] [Related]
18. Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
Gwela A; Siddhanathi P; Chapman RW; Travis S; Powrie F; Arancibia-Cárcamo CV; Geremia A
J Crohns Colitis; 2017 Sep; 11(9):1124-1134. PubMed ID: 28383652
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155 is involved in the pathogenesis of ulcerative colitis by targeting FOXO3a.
Min M; Peng L; Yang Y; Guo M; Wang W; Sun G
Inflamm Bowel Dis; 2014 Apr; 20(4):652-9. PubMed ID: 24583476
[TBL] [Abstract][Full Text] [Related]
20. Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway.
Kempinska-Podhorodecka A; Milkiewicz M; Wasik U; Ligocka J; Zawadzki M; Krawczyk M; Milkiewicz P
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
